Lymph node status and survival in cutaneous malignant melanoma—sentinel lymph node biopsy impact
- 1 September 2003
- journal article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 29 (7) , 611-618
- https://doi.org/10.1016/s0748-7983(03)00118-5
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Sentinel lymph node biopsy in melanoma patients with clinically negative regional lymph nodes – one institution's experienceMelanoma Research, 2003
- Final Version of the American Joint Committee on Cancer Staging System for Cutaneous MelanomaJournal of Clinical Oncology, 2001
- Factors that predict the presence of sentinel lymph node metastasis in patients with melanomaSurgery, 2001
- The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanomaCancer, 2001
- Sentinel Lymph Node Biopsy in Cutaneous Melanoma: The WHO Melanoma Program ExperienceAnnals of Surgical Oncology, 2000
- Regional nodal surgery for melanoma impacts recurrence rates and survival.Annals of Surgical Oncology, 2000
- Efficacy of Lymphatic Mapping, Sentinel Lymphadenectomy, and Selective Complete Lymph Node Dissection as a Therapeutic Procedure for Early-Stage MelanomaAnnals of Surgical Oncology, 1999
- Multi-Institutional Melanoma Lymphatic Mapping Experience: The Prognostic Value of Sentinel Lymph Node Status in 612 Stage I or II Melanoma PatientsJournal of Clinical Oncology, 1999
- Intraoperative Radiolymphoscintigraphy Improves Sentinel Lymph Node Identification for Patients with MelanomaAnnals of Surgery, 1996
- Technical Details of Intraoperative Lymphatic Mapping for Early Stage MelanomaArchives of Surgery, 1992